US Patent Issued to Genentech, Hoffmann-La Roche on April 21 for "Methods of treating relapsing multiple sclerosis using an inhibitor of Bruton's tyrosine kinase" (Swiss, American Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,376, issued on April 21, was assigned to Genentech Inc. (South San Francisco, Calif.) and Hoffmann-La Roche Inc. (Little Falls, N.J.).

"Methods of treating relapsing multiple sclerosis using an inhibitor of Bruton's tyrosine kinase" was invented by Hideki Garren (Palo Alto, Calif.), Edmond Huatung Teng (San Mateo, Calif.), Aurelien Viaccoz (Basel, Switzerland) and Hans-Christian Von Buedingen (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating Relapsing Multiple Sclerosis (RMS) in a subject in need thereof, by administering to the subject about 200 mg of fenebrutinib twice daily, or an equivale...